CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 22, 2004--POZEN Inc.
(NASDAQ: POZN), announced today that it will release first quarter
results on April 29, 2004, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time of a discussion by POZEN management of the earnings and
business results. The webcast can be accessed on POZEN's website at
www.pozen.com and will be archived and available for replay. The first
quarter earnings release can be accessed in the News section of
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Product development efforts
are focused on diseases with unmet medical needs where POZEN can
improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has developed the largest and most advanced product
pipeline in the field of migraine. POZEN has development and
commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and
Nycomed. The company's common stock is traded on The Nasdaq Stock
Market under the symbol "POZN". For detailed company information,
including copies of this and other press releases, see POZEN's
Lisa Barthelemy, 919-913-1044
John Barnhardt, 919-913-1030